药品注册申请号:200411
申请类型:ANDA (仿制药申请)
申请人:IMPAX LABS INC
申请人全名:IMPAX LABORATORIES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 20MG No No AB 2016/04/12 2016/04/12 Discontinued
002 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 30MG No No AB 2016/04/12 Discontinued
003 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 50MG No No AB 2016/04/12 Discontinued
004 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 60MG No No AB 2016/04/12 Discontinued
005 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 80MG No No AB 2016/04/12 Discontinued
006 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 100MG No No AB 2016/04/12 Discontinued
007 MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 40MG No No None 2018/07/25 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/10/31 SUPPL-25(补充) Approval REMS
2023/12/15 SUPPL-23(补充) Approval Labeling STANDARD
2023/12/15 SUPPL-22(补充) Approval Labeling STANDARD
2023/12/06 SUPPL-21(补充) Approval Labeling STANDARD
2023/12/06 SUPPL-20(补充) Approval Labeling STANDARD
2023/12/06 SUPPL-18(补充) Approval Labeling STANDARD
2023/12/06 SUPPL-14(补充) Approval Labeling STANDARD
2018/09/18 SUPPL-10(补充) Approval REMS
2018/07/19 SUPPL-5(补充) Approval Labeling STANDARD
2017/05/26 SUPPL-6(补充) Approval REMS
2017/05/19 SUPPL-4(补充) Approval Manufacturing (CMC)
2016/09/30 SUPPL-3(补充) Approval REMS
2016/04/20 SUPPL-1(补充) Approval REMS
2016/04/12 ORIG-1(原始申请) Approval Not Applicable
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:MORPHINE SULFATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:20MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 002 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 001 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 20MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
活性成分:MORPHINE SULFATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:30MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 003 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 30MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 002 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 30MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
活性成分:MORPHINE SULFATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:50MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 004 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 50MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 003 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 50MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
活性成分:MORPHINE SULFATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:60MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 005 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 004 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 60MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
活性成分:MORPHINE SULFATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:80MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 006 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2013/06/03 UPSHER SMITH LABS
200411 005 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 80MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
活性成分:MORPHINE SULFATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:100MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
202104 007 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 100MG Prescription No Yes AB 2013/06/03 UPSHER SMITH LABS
200411 006 ANDA MORPHINE SULFATE MORPHINE SULFATE CAPSULE, EXTENDED RELEASE;ORAL 100MG Discontinued No No AB 2016/04/12 IMPAX LABS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database